The Switzer Prize honors revolutionary discoveries in basic research in the biological and biomedical sciences and celebrates recent advances with the potential to inspire transformative breakthroughs in medicine. The prize is awarded to an individual investigator whose recent work has revealed new paradigms, illuminated biological processes or pathways, or explained the origins of pathologies or diseases. The recent work must show the potential for continued outstanding contributions to the field.
Nominations are open to national and international candidates from any institution. Nominations may be made by an individual or institutions, but self- nominations are prohibited.
To nominate a researcher for the 2022 Switzer Prize, please complete a nomination form and submit a letter of nomination along with a short summary. The summary should include no more than 100 words summarizing the nominee’s most important accomplishments, in addition to the letter of recommendation explaining his or her contributions to basic research in the biological or biomedical sciences.
Nominations may be made only via this website. Nominations will not be accepted by email or delivery of hard copies.
The deadline for nominations is March 31, 2022.
The winner, to be named in Spring 2022, will receive a $25,000 honorarium. The recipient will deliver the annual Switzer Prize lecture at the David Geffen School of Medicine at UCLA in Fall 2022.
Please direct any questions about the nomination process to Dion Baybridge at (310) 794-7374 or DBaybridge@mednet.ucla.edu.
